GMED logo

Globus Medical, Inc. Stock Price

NYSE:GMED Community·US$8.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 37 Fair Values set on narratives written by author

GMED Share Price Performance

US$60.48
-9.42 (-13.48%)
42.9% undervalued intrinsic discount
US$106.00
Fair Value
US$60.48
-9.42 (-13.48%)
42.5% undervalued intrinsic discount
US$105.25
Fair Value
Price US$60.48
AnalystHighTarget US$105.25
AnalystConsensusTarget US$80.30
AnalystLowTarget US$65.00

GMED Community Narratives

AnalystHighTarget·Updated
Fair Value US$106 42.9% undervalued intrinsic discount

Aging Demographics And Digital Trends Will Transform Orthopedic Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$80.3 24.7% undervalued intrinsic discount

Aging Demographics And Robotics Will Expand Spine And Orthopedic Care

0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$65 7.0% undervalued intrinsic discount

Integration And Supply Risks Will Curb Margins Yet Unlock Value

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent GMED News & Updates

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Sep 12
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E

Jul 21
What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E

Globus Medical, Inc. Key Details

US$2.6b

Revenue

US$864.0m

Cost of Revenue

US$1.8b

Gross Profit

US$1.4b

Other Expenses

US$356.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
2.64
Gross Margin
67.10%
Net Profit Margin
13.58%
Debt/Equity Ratio
0%

Globus Medical, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
4 Rewards

About GMED

Founded
2003
Employees
5300
CEO
Keith Pfeil
WebsiteView website
www.globusmedical.com

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.9%
  • 3 Months: 8.7%
  • 1 Year: 18.4%
  • Year to Date: 14.8%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 6.4%. Meanwhile, the market is actually up 18% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›